Bank of Nova Scotia’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $2.17M | Buy |
|
|||||
|
2025
Q3 | $585K | Buy |
|
|||||
|
2025
Q2 | $516K | Sell |
|
|||||
|
2025
Q1 | $921K | Sell |
|
|||||
|
2024
Q4 | $1.02M | Buy |
|
|||||
|
2024
Q3 | $944K | Sell |
|
|||||
|
2024
Q2 | $1.15M | Sell |
|
|||||
|
2024
Q1 | $13.4M | Sell |
|
|||||
|
2023
Q4 | $26.8M | Buy |
|
|||||
|
2023
Q3 | $24.1M | Buy |
|
|||||
|
2023
Q2 | $11M | Buy |
|
|||||
|
2023
Q1 | $12.4M | Sell |
|
|||||
|
2022
Q4 | $22.4M | Buy |
|
|||||
|
2022
Q3 | $360K | Sell |
|
|||||
|
2022
Q2 | $399K | Sell |
|
|||||
|
2022
Q1 | $455K | Buy |
|
|||||
|
2021
Q4 | $320K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $5.66M | Buy |
|